General Information of Drug Off-Target (DOT) (ID: OT4BE2M4)

DOT Name Protein phosphatase Slingshot homolog 1 (SSH1)
Synonyms EC 3.1.3.16; EC 3.1.3.48; SSH-like protein 1; SSH-1L; hSSH-1L
Gene Name SSH1
Related Disease
Advanced cancer ( )
Breast cancer ( )
Breast carcinoma ( )
Colorectal carcinoma ( )
Neoplasm ( )
Porokeratosis ( )
Disseminated superficial actinic porokeratosis ( )
Gastric cancer ( )
High blood pressure ( )
Stomach cancer ( )
UniProt ID
SSH1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
3.1.3.16; 3.1.3.48
Pfam ID
PF08766 ; PF00782
Sequence
MALVTLQRSPTPSAASSSASNSELEAGSEEDRKLNLSLSESFFMVKGAALFLQQGSSPQG
QRSLQHPHKHAGDLPQHLQVMINLLRCEDRIKLAVRLESAWADRVRYMVVVYSSGRQDTE
ENILLGVDFSSKESKSCTIGMVLRLWSDTKIHLDGDGGFSVSTAGRMHIFKPVSVQAMWS
ALQVLHKACEVARRHNYFPGGVALIWATYYESCISSEQSCINEWNAMQDLESTRPDSPAL
FVDKPTEGERTERLIKAKLRSIMMSQDLENVTSKEIRNELEKQMNCNLKELKEFIDNEML
LILGQMDKPSLIFDHLYLGSEWNASNLEELQGSGVDYILNVTREIDNFFPGLFAYHNIRV
YDEETTDLLAHWNEAYHFINKAKRNHSKCLVHCKMGVSRSASTVIAYAMKEFGWPLEKAY
NYVKQKRSITRPNAGFMRQLSEYEGILDASKQRHNKLWRQQTDSSLQQPVDDPAGPGDFL
PETPDGTPESQLPFLDDAAQPGLGPPLPCCFRRLSDPLLPSPEDETGSLVHLEDPEREAL
LEEAAPPAEVHRPARQPQQGSGLCEKDVKKKLEFGSPKGRSGSLLQVEETEREEGLGAGR
WGQLPTQLDQNLLNSENLNNNSKRSCPNGMEDDAIFGILNKVKPSYKSCADCMYPTASGA
PEASRERCEDPNAPAICTQPAFLPHITSSPVAHLASRSRVPEKPASGPTEPPPFLPPAGS
RRADTSGPGAGAALEPPASLLEPSRETPKVLPKSLLLKNSHCDKNPPSTEVVIKEESSPK
KDMKPAKDLRLLFSNESEKPTTNSYLMQHQESIIQLQKAGLVRKHTKELERLKSVPADPA
PPSRDGPASRLEASIPEESQDPAALHELGPLVMPSQAGSDEKSEAAPASLEGGSLKSPPP
FFYRLDHTSSFSKDFLKTICYTPTSSSMSSNLTRSSSSDSIHSVRGKPGLVKQRTQEIET
RLRLAGLTVSSPLKRSHSLAKLGSLTFSTEDLSSEADPSTVADSQDTTLSESSFLHEPQG
TPRDPAATSKPSGKPAPENLKSPSWMSKS
Function
Protein phosphatase which regulates actin filament dynamics. Dephosphorylates and activates the actin binding/depolymerizing factor cofilin, which subsequently binds to actin filaments and stimulates their disassembly. Inhibitory phosphorylation of cofilin is mediated by LIMK1, which may also be dephosphorylated and inactivated by this protein.
KEGG Pathway
Axon guidance (hsa04360 )
Regulation of actin cytoskeleton (hsa04810 )

Molecular Interaction Atlas (MIA) of This DOT

10 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Advanced cancer DISAT1Z9 Strong Biomarker [1]
Breast cancer DIS7DPX1 Strong Altered Expression [2]
Breast carcinoma DIS2UE88 Strong Altered Expression [2]
Colorectal carcinoma DIS5PYL0 Strong Altered Expression [3]
Neoplasm DISZKGEW Strong Biomarker [3]
Porokeratosis DISJPL2I Strong Genetic Variation [4]
Disseminated superficial actinic porokeratosis DISELZ77 Limited Biomarker [5]
Gastric cancer DISXGOUK Limited Altered Expression [6]
High blood pressure DISY2OHH Limited Biomarker [7]
Stomach cancer DISKIJSX Limited Altered Expression [6]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
4 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Protein phosphatase Slingshot homolog 1 (SSH1). [8]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene affects the methylation of Protein phosphatase Slingshot homolog 1 (SSH1). [15]
PMID28870136-Compound-52 DMFDERP Patented PMID28870136-Compound-52 decreases the phosphorylation of Protein phosphatase Slingshot homolog 1 (SSH1). [16]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the methylation of Protein phosphatase Slingshot homolog 1 (SSH1). [17]
------------------------------------------------------------------------------------
7 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Protein phosphatase Slingshot homolog 1 (SSH1). [9]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Protein phosphatase Slingshot homolog 1 (SSH1). [10]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate increases the expression of Protein phosphatase Slingshot homolog 1 (SSH1). [11]
Arsenic DMTL2Y1 Approved Arsenic affects the expression of Protein phosphatase Slingshot homolog 1 (SSH1). [12]
Calcitriol DM8ZVJ7 Approved Calcitriol increases the expression of Protein phosphatase Slingshot homolog 1 (SSH1). [13]
Carbamazepine DMZOLBI Approved Carbamazepine affects the expression of Protein phosphatase Slingshot homolog 1 (SSH1). [14]
Phencyclidine DMQBEYX Investigative Phencyclidine decreases the expression of Protein phosphatase Slingshot homolog 1 (SSH1). [18]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Drug(s)

References

1 SSH3 facilitates colorectal cancer cell invasion and metastasis by affecting signaling cascades involving LIMK1/Rac1.Am J Cancer Res. 2019 May 1;9(5):1061-1073. eCollection 2019.
2 Slingshot-1L, a cofilin phosphatase, induces primary breast cancer metastasis.Oncotarget. 2017 Aug 3;8(39):66195-66203. doi: 10.18632/oncotarget.19855. eCollection 2017 Sep 12.
3 LIMK/cofilin pathway and Slingshot are implicated in human colorectal cancer progression and chemoresistance.Virchows Arch. 2018 May;472(5):727-737. doi: 10.1007/s00428-018-2298-0. Epub 2018 Jan 19.
4 Fine mapping and identification of a candidate gene SSH1 in disseminated superficial actinic porokeratosis.Hum Mutat. 2004 Nov;24(5):438. doi: 10.1002/humu.9283.
5 Identification of a genetic locus for autosomal dominant disseminated superficial actinic porokeratosis on chromosome 1p31.3-p31.1.Hum Genet. 2008 Jun;123(5):507-13. doi: 10.1007/s00439-008-0504-x. Epub 2008 Apr 29.
6 SSH1 expression is associated with gastric cancer progression and predicts a poor prognosis.BMC Gastroenterol. 2018 Jan 16;18(1):12. doi: 10.1186/s12876-018-0739-5.
7 The cofilin phosphatase slingshot homolog 1 restrains angiotensin II-induced vascular hypertrophy and fibrosis in vivo.Lab Invest. 2019 Mar;99(3):399-410. doi: 10.1038/s41374-018-0116-6. Epub 2018 Oct 5.
8 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
9 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
10 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
11 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
12 Drinking-water arsenic exposure modulates gene expression in human lymphocytes from a U.S. population. Environ Health Perspect. 2008 Apr;116(4):524-31. doi: 10.1289/ehp.10861.
13 Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005 Nov;19(11):2685-95.
14 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
15 Effect of aflatoxin B(1), benzo[a]pyrene, and methapyrilene on transcriptomic and epigenetic alterations in human liver HepaRG cells. Food Chem Toxicol. 2018 Nov;121:214-223. doi: 10.1016/j.fct.2018.08.034. Epub 2018 Aug 26.
16 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
17 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
18 Microarray Analysis of Gene Expression Alteration in Human Middle Ear Epithelial Cells Induced by Asian Sand Dust. Clin Exp Otorhinolaryngol. 2015 Dec;8(4):345-53. doi: 10.3342/ceo.2015.8.4.345. Epub 2015 Nov 10.